• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RT-PCR 检测的、无需住院的 SARS-CoV-2 感染患者中的哮喘患病率。

Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.

机构信息

Section of Respiratory Medicine, Hospital General Universitario de Elche, Alicante, Spain; Department of Clinical Medicine, Universidad Miguel Hernandez de Elche, Alicante, Spain.

Section of Respiratory Medicine, Hospital General Universitario de Elche, Alicante, Spain.

出版信息

Respir Med. 2020 Sep;171:106084. doi: 10.1016/j.rmed.2020.106084. Epub 2020 Jul 4.

DOI:10.1016/j.rmed.2020.106084
PMID:32658837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7334641/
Abstract

INTRODUCTION

The prevalence of asthma in patients hospitalized with SARS-CoV-2 has been studied and varies widely in the different series. However, the prevalence in SARS-infected patients not requiring hospitalization is not known. The objective of this study was to analyze the presence of asthma in a consecutive series of patients who tested positive in the RT-PCR assay for SARS-CoV-2 and did not require hospital admission.

METHODS AND RESULTS

A total of 218 patients (58% of those who tested positive) did not require hospitalization; they had a median age of 45 years (IQR 34-57) and 57% were female. Six patients (2.8%) had a previous diagnosis of asthma. Only one patient developed a mild aggravation of asthma symptoms associated with SARS-CoV-2 infection.

CONCLUSIONS

Few patients with asthma were infected by SARS-CoV-2, and this infection was not a significant cause of asthma exacerbation.

摘要

简介

在因 SARS-CoV-2 住院的患者中,哮喘的患病率已被研究过,并且在不同的系列中差异很大。但是,尚不清楚未住院的 SARS 感染患者的患病率。本研究的目的是分析连续系列 SARS-CoV-2 RT-PCR 检测呈阳性且无需住院的患者中哮喘的存在情况。

方法和结果

共有 218 名患者(占检测呈阳性者的 58%)无需住院;他们的中位年龄为 45 岁(IQR 34-57),其中 57%为女性。有 6 名患者(2.8%)有哮喘的既往诊断。只有一名患者因 SARS-CoV-2 感染而出现哮喘症状轻度加重。

结论

感染 SARS-CoV-2 的哮喘患者很少,并且这种感染不是哮喘加重的主要原因。

相似文献

1
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.RT-PCR 检测的、无需住院的 SARS-CoV-2 感染患者中的哮喘患病率。
Respir Med. 2020 Sep;171:106084. doi: 10.1016/j.rmed.2020.106084. Epub 2020 Jul 4.
2
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.COVID-19 住院和非住院患者中哮喘的患病率和特征。
J Allergy Clin Immunol. 2020 Aug;146(2):307-314.e4. doi: 10.1016/j.jaci.2020.06.010. Epub 2020 Jun 15.
3
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.住院哮喘患者的 SARS-CoV-2 肺炎并未引发严重恶化。
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2600-2607. doi: 10.1016/j.jaip.2020.06.032. Epub 2020 Jun 27.
4
Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.意大利中部一所教学医院的卫生工作者(HWs)中 SARS-CoV-2 感染的流行率和诊断检测性能。
Int J Environ Res Public Health. 2020 Jun 19;17(12):4417. doi: 10.3390/ijerph17124417.
5
Clinical course and characteristics of patients with coronavirus disease 2019 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉2019冠状病毒病患者的临床过程及特征:一项单中心、回顾性、观察性研究
Aging (Albany NY). 2020 Aug 24;12(16):15946-15953. doi: 10.18632/aging.103745.
6
Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.一名克罗恩病患者的新冠病毒阳性持续时间延长
Inflamm Bowel Dis. 2020 Sep 18;26(10):e124. doi: 10.1093/ibd/izaa175.
7
Utility and safety of bronchoscopy during the SARS-CoV-2 outbreak in Italy: a retrospective, multicentre study.意大利 SARS-CoV-2 爆发期间支气管镜检查的实用性和安全性:一项回顾性、多中心研究。
Eur Respir J. 2020 Oct 15;56(4). doi: 10.1183/13993003.02767-2020. Print 2020 Oct.
8
Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.家长对住院儿童进行 2019 冠状病毒病检测:大流行期间重新思考感染控制。
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):564-565. doi: 10.1093/jpids/piaa103.
9
An understanding of discordant SARS-CoV-2 test results: an examination of the data from a central Auckland laboratory.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测结果不一致的理解:奥克兰市中心一家实验室的数据检查
N Z Med J. 2020 Jul 31;133(1519):81-88.
10
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.需要住院的 COVID-19 肺炎合并哮喘患者的特征和结局。
Eur Respir J. 2020 Nov 5;56(5). doi: 10.1183/13993003.01875-2020. Print 2020 Nov.

引用本文的文献

1
Human Epidemiology and Response to SARS-CoV-2 (HEROS): objectives, design, and enrollment results of a 12-city remote observational surveillance study of households with children, using direct-to-participant methods.人类流行病学和对 SARS-CoV-2 的反应(HEROS):一项使用直接参与方法对有儿童的家庭进行的 12 个城市远程观察性监测研究的目标、设计和入组结果。
Am J Epidemiol. 2024 Oct 7;193(10):1329-1338. doi: 10.1093/aje/kwae077.
2
Prevalence of acute infection in adults with asthma exacerbation: A systematic review and meta-analysis.哮喘加重的成人急性感染患病率:一项系统评价和荟萃分析。
Ann Thorac Med. 2023 Jul-Sep;18(3):132-151. doi: 10.4103/atm.atm_422_22. Epub 2023 Jul 19.
3
Is asthma associated with COVID-19 infection? A UK Biobank analysis.哮喘与新冠病毒感染有关联吗?一项英国生物银行分析。
ERJ Open Res. 2021 Nov 29;7(4). doi: 10.1183/23120541.00309-2021. eCollection 2021 Oct.
4
Risk, Mechanisms and Implications of Asthma-Associated Infectious and Inflammatory Multimorbidities (AIMs) among Individuals With Asthma: a Systematic Review and a Case Study.哮喘患者中哮喘相关感染性和炎症性多重疾病(AIMs)的风险、机制及影响:一项系统评价和病例研究
Allergy Asthma Immunol Res. 2021 Sep;13(5):697-718. doi: 10.4168/aair.2021.13.5.697.
5
Asthma and COVID-19 risk: a systematic review and meta-analysis.哮喘与 COVID-19 风险:系统评价和荟萃分析。
Eur Respir J. 2022 Mar 31;59(3). doi: 10.1183/13993003.01209-2021. Print 2022 Mar.
6
Symptoms in patients with asthma infected by SARS-CoV-2.感染 SARS-CoV-2 的哮喘患者的症状。
Respir Med. 2021 Aug-Sep;185:106495. doi: 10.1016/j.rmed.2021.106495. Epub 2021 Jun 8.
7
COVID-19 and bronchial asthma: current perspectives.2019冠状病毒病与支气管哮喘:当前观点
Glob Health Med. 2021 Apr 30;3(2):67-72. doi: 10.35772/ghm.2020.01117.
8
Psychosocial impact of Covid-19 outbreak on Italian asthmatic children and their mothers in a post lockdown scenario.新冠疫情封锁措施解除后,新冠疫情对意大利哮喘儿童及其母亲的心理社会影响。
Sci Rep. 2021 Apr 28;11(1):9152. doi: 10.1038/s41598-021-88152-4.
9
Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis.2019 冠状病毒病患者的哮喘:系统评价和荟萃分析。
Ann Allergy Asthma Immunol. 2021 May;126(5):524-534. doi: 10.1016/j.anai.2021.02.013. Epub 2021 Feb 18.
10
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease.成人 COVID-19 患者中的哮喘。患病率和严重疾病风险。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):893-905. doi: 10.1164/rccm.202008-3266OC.

本文引用的文献

1
Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis.哮喘患者中病毒性呼吸道感染的流行情况:荟萃回归分析的结果。
Respir Med. 2020 Nov;173:106020. doi: 10.1016/j.rmed.2020.106020. Epub 2020 May 15.
2
Asthma and COPD in Hospitalized COVID-19 Patients.住院COVID-19患者中的哮喘和慢性阻塞性肺疾病
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.
3
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
4
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?哮喘与新冠病毒病:哮喘是导致严重后果的风险因素吗?
Allergy. 2020 Jul;75(7):1543-1545. doi: 10.1111/all.14348.
5
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
6
COVID-19 with Different Severities: A Multicenter Study of Clinical Features.不同严重程度的 COVID-19:一项多中心临床特征研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.
7
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?慢性呼吸道疾病或其治疗是否会影响感染SARS-CoV-2的风险?
Lancet Respir Med. 2020 May;8(5):436-438. doi: 10.1016/S2213-2600(20)30167-3. Epub 2020 Apr 3.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响:系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
10
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.格隆溴铵、福莫特罗和布地奈德对人鼻和气管上皮细胞原代培养物中冠状病毒HCoV-229E复制及细胞因子产生的抑制作用。
Respir Investig. 2020 May;58(3):155-168. doi: 10.1016/j.resinv.2019.12.005. Epub 2020 Feb 21.